{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:37:58Z","timestamp":1791916678742,"version":"4.3.4"},"reference-count":30,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12,1]]},"abstract":"<jats:p>Objective. To determine the diagnostic properties of quantitative C-reactive protein (CRP) associated with clinically undetectable serious bacterial infection (SBI) in febrile children 1 to 36 months of age.<\/jats:p><jats:p>Methods. Febrile children presenting to a pediatric emergency department (ED) with ages ranging from 1 to 36 months, temperatures \u226539\u00b0C, and clinically undetectable source of fever were enrolled in this prospective cohort study. Demographic information, ED temperature, duration of fever, and clinical evaluation using the Yale observation scale were recorded at the time of the initial evaluation. The white blood cell count (WBC), band count, absolute neutrophil count (ANC), and CRP concentration were measured at the same time. All patients received blood cultures and either a screening urinalysis or urine culture. A chest radiograph was obtained at the discretion of the ED physician. Patients with history of using antibiotics within 1 week of their presentation to the ED were excluded. The main outcome result was the presence of laboratory or radiographically proven SBI (bacteremia, meningitis, urinary tract infection, pneumonia, septic arthritis, and osteomyelitis).<\/jats:p><jats:p>Results. Seventy-seven patients were enrolled in the study. Fourteen (18%) had a SBI (6 urinary tract infection; 4 pneumonia, including 1 patient with Streptococcus pneumoniae bacteremia; and 4 occult S pneumoniae bacteremia), and 63 had no SBI. The 2 groups were indistinguishable in age, sex, ED temperature, duration of fever, and Yale observation scale. CRP concentration, WBC, and ANC were significantly different between the 2 groups. In a multivariate logistic regression analysis, only CRP remained as a predictor of SBI (Beta = 0.76, 95% confidence interval [CI]: 0.64, 0.89). Receiver-operating characteristic analysis demonstrated CRP (area under curve [AUC] 0.905, standard error [SE] 0.05, 95% CI: 0.808, 1.002) to be superior to ANC (AUC 0.805, SE 0.051, 95% CI: 0.705, 0.905) and to WBC (AUC 0.761, SE 0.068, 95% CI: 0.628, 0.895). A CRP cutoff point of 7 was determined to maximize both sensitivity and specificity (sensitivity 79%, specificity 91%, likelihood ratio 8.3, 95% CI: 3.8, 27.3). Multilevel likelihood ratios and posttest probabilities were calculated for a variety of CRP levels. A CRP concentration of &amp;lt;5 mg\/dL effectively ruled out SBI (likelihood ratio 0.087, 95% CI: 0.02, 0.38, posttest probability of SBI 1.9%).<\/jats:p><jats:p>Conclusions. Quantitative CRP concentration is a valuable laboratory test in the evaluation of febrile young children who are at risk for occult bacteremia and SBI, with a better predictive value than the WBC or ANC.<\/jats:p>","DOI":"10.1542\/peds.108.6.1275","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:55:51Z","timestamp":1092441351000},"page":"1275-1279","source":"Crossref","is-referenced-by-count":158,"title":["C-Reactive Protein in Febrile Children 1 to 36 Months of Age With Clinically Undetectable Serious Bacterial Infection"],"prefix":"10.1542","volume":"108","author":[{"given":"Patrick N.","family":"Pulliam","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Temple University School of Medicine, Temple University Children\u2019s Medical Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdy W.","family":"Attia","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Emergency Medicine, Jefferson Medical College, duPont Hospital for Children, Wilmington, Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Cronan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Emergency Medicine, Jefferson Medical College, duPont Hospital for Children, Wilmington, Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2001,12,1]]},"reference":[{"key":"2021121003493536600_R1","doi-asserted-by":"crossref","unstructured":"Lee GM, Harper MB. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med.1998;152:624\u2013628","DOI":"10.1001\/archpedi.152.7.624"},{"key":"2021121003493536600_R2","unstructured":"Soman M. Characteristics and management of febrile young children seen in a university family practice. J Fam Pract.1985;21:117\u2013122"},{"key":"2021121003493536600_R3","doi-asserted-by":"crossref","unstructured":"Isaacman DJ, Shults J, Gross TK, et al. Predictors of bacteremia in febrile children 3 to 36 months of age. Pediatrics.2000;106:977\u2013982","DOI":"10.1542\/peds.106.5.977"},{"key":"2021121003493536600_R4","doi-asserted-by":"crossref","unstructured":"Alpern ER, Alesandrini EA, Bell LM, Shaw KN, McGowan KL. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics.2000;106:505\u2013511","DOI":"10.1542\/peds.106.3.505"},{"key":"2021121003493536600_R5","doi-asserted-by":"crossref","unstructured":"Kupperman N, Fleisher GR, Jaffe DM. Predictors of occult bacteremia in young febrile children. Ann Emerg Med.1998;31:679\u2013687","DOI":"10.1016\/S0196-0644(98)70225-2"},{"key":"2021121003493536600_R6","doi-asserted-by":"crossref","unstructured":"Shaw KN, Gorelick MG, McGowan KL, McDaniel Yakscoe M, Schwartz JS. Prevalence of urinary tract infection in febrile young children in the emergency department. Pediatrics.1998;102(2):. Available at: http:\/\/www.pediatrics.org\/cgi\/content\/full\/102\/2\/e16","DOI":"10.1542\/peds.102.2.e16"},{"key":"2021121003493536600_R7","doi-asserted-by":"crossref","unstructured":"Bachur R, Perry H, Harper M. Occult pneumonias: empiric chest radiographs in febrile children with leukocytosis. Ann Emerg Med.1999;33:166\u2013173","DOI":"10.1016\/S0196-0644(99)70390-2"},{"key":"2021121003493536600_R8","doi-asserted-by":"crossref","unstructured":"Teach SJ, Fleisher GR, Occult Bacteremia Study Group. Efficacy of an observation scale in detecting bacteremia in febrile children three to thirty-six months of age, treated as outpatients. J Pediatr.1995;126:877\u2013881","DOI":"10.1016\/S0022-3476(95)70200-8"},{"key":"2021121003493536600_R9","doi-asserted-by":"crossref","unstructured":"Kaplan RL, Harper MB, Baskin MN, Macone AB, Mandl KD. Time to detection of positive cultures in 28- to 90-day-old febrile infants. Pediatrics. 2000;106(6). Available at: http:\/\/www.pediatrics.org\/cgi\/content\/full\/106\/6\/e74","DOI":"10.1542\/peds.106.6.e74"},{"key":"2021121003493536600_R10","doi-asserted-by":"crossref","unstructured":"Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics.1993;92:1\u201312","DOI":"10.1016\/S0196-0644(05)80991-6"},{"key":"2021121003493536600_R11","doi-asserted-by":"crossref","unstructured":"Gorelick MG, Shaw KN. Clinical decision rule to identify febrile young girls at risk for urinary tract infection. Arch Pediatr Adolesc Med.2000;154:386\u2013390","DOI":"10.1001\/archpedi.154.4.386"},{"key":"2021121003493536600_R12","doi-asserted-by":"crossref","unstructured":"Kramer MS, Tange SM, Drummond KN, Mills EL. Urine testing in young febrile children: a risk-benefit analysis. J Pediatr.1994;125:6\u201313","DOI":"10.1016\/S0022-3476(94)70114-8"},{"key":"2021121003493536600_R13","doi-asserted-by":"crossref","unstructured":"Baraff LJ. Management of fever without source in infants and children. Ann Emerg Med.2000;36:602\u2013614","DOI":"10.1067\/mem.2000.110820"},{"key":"2021121003493536600_R14","doi-asserted-by":"crossref","unstructured":"McCarthy PL, Jekel JF, Dolan TF. Comparison of acute-phase reactants in pediatric patients with fever. Pediatrics.1978;62:716\u2013720","DOI":"10.1542\/peds.62.5.716"},{"key":"2021121003493536600_R15","doi-asserted-by":"crossref","unstructured":"Bennish M, Been MO, Ormiste V. C-reactive protein and zeta sedimentation rate as indicators of bacteremia in pediatric patients. J Pediatr.1984;104:729\u2013732","DOI":"10.1016\/S0022-3476(84)80953-1"},{"key":"2021121003493536600_R16","doi-asserted-by":"crossref","unstructured":"Putto A, Ruuskanen O, Meurman O, et al. C-reactive protein in the evaluation of febrile illness. Arch Dis Childhood.1986;61:24\u201329","DOI":"10.1136\/adc.61.1.24"},{"key":"2021121003493536600_R17","doi-asserted-by":"crossref","unstructured":"Peltola H, Jaakkola M. C-reactive protein in early detection of bacteremic versus viral infections in imunocompetent and compromised children. J Pediatr.1988;113:641\u2013646","DOI":"10.1016\/S0022-3476(88)80372-X"},{"key":"2021121003493536600_R18","doi-asserted-by":"crossref","unstructured":"Berger RM, Berger MY, van Steensel-Moll HA, Dzoljic-Danilovic G, Derksen-Lubsen G. A predictive model to estimate the risk of serious bacterial infection in febrile infants. Eur J Pediatr.1996;155:468\u2013473","DOI":"10.1007\/BF01955183"},{"key":"2021121003493536600_R19","doi-asserted-by":"crossref","unstructured":"Lacour AG, Gervaix A, Zamora SA, et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur J Pediatr.2001;160:95\u2013100","DOI":"10.1007\/s004310000681"},{"key":"2021121003493536600_R20","doi-asserted-by":"crossref","unstructured":"McCarthy PL, Lembo RM, Baron MA, Fink HD, Cicchetti DV. Predictive value of abnormal physical examination findings in ill-appearing and well-appearing febrile children. Pediatrics.1985;76:167\u2013171","DOI":"10.1542\/peds.76.2.167"},{"key":"2021121003493536600_R21","doi-asserted-by":"crossref","unstructured":"Rubin LG, Carmody L. Pneumococcal and haemophilus influenzae type b antigen detection in children at risk for occult bacteremia. Pediatrics.1987;80:92\u201396","DOI":"10.1542\/peds.80.1.92"},{"key":"2021121003493536600_R22","doi-asserted-by":"crossref","unstructured":"Lembo RM, Marchant CD. Acute phase reactants and risk of bacterial meningitis among febrile infants and children. Ann Emerg Med.1991;20:36\u201344","DOI":"10.1016\/S0196-0644(05)81115-1"},{"key":"2021121003493536600_R23","doi-asserted-by":"crossref","unstructured":"Sormunen P, Kallio MJT, Kilpi T, Peltola H. C-reactive protein is useful in distinguishing Gram stain-negative bacterial meningitis from viral meningitis in children. J Pediatr.1999;134:725\u2013729","DOI":"10.1016\/S0022-3476(99)70288-X"},{"key":"2021121003493536600_R24","doi-asserted-by":"crossref","unstructured":"Black S, Shinefield H, Fireman B, et al. Efficacy, safety, and immunogenicity of heptavalent pneumococcal vaccine in children. Pediatr Infect Dis J.2000;19:187\u2013195","DOI":"10.1097\/00006454-200003000-00003"},{"key":"2021121003493536600_R25","unstructured":"Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. 2nd ed. Boston, MA: Little, Brown and Company; 1991:119\u2013139"},{"key":"2021121003493536600_R26","doi-asserted-by":"crossref","unstructured":"Gorelick MH, Shaw KN. Screening tests for urinary tract infection in children: a meta-analysis. Pediatrics.1999;104(5):. Available at: http:\/\/www.pediatrics.org\/cgi\/content\/full\/104\/5\/e54","DOI":"10.1542\/peds.104.5.e54"},{"key":"2021121003493536600_R27","doi-asserted-by":"crossref","unstructured":"Hoberman A, Wald ER, Penchansky L, Reynolds EA, Young S. Enhanced urinalysis as a screening test for urinary tract infection.Pediatrics.1993;91:1196\u20131199","DOI":"10.1542\/peds.91.6.1196"},{"key":"2021121003493536600_R28","doi-asserted-by":"crossref","unstructured":"Jones RG, Bass JW. Febrile children with no focus of infection: a survey of their management by primary care physicians. Pediatr Infect Dis J.1993;12:179\u2013183","DOI":"10.1097\/00006454-199303000-00001"},{"key":"2021121003493536600_R29","doi-asserted-by":"crossref","unstructured":"Dahler-Eriksen BS, Lassen JF, Petersen PH, Lund ED, Lauritzen T, Brandslund I. Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of different plots. Clin Chem.1997;43:2064\u20132075","DOI":"10.1093\/clinchem\/43.11.2064"},{"key":"2021121003493536600_R30","unstructured":"NycoCard CRP. Manufactured by Axis-Shield PoC AS, Oslo, Norway. Information available at: http:\/\/www.axis-shield-poc.com\/nycocrp.htm. Accessed July 25, 2001"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/108\/6\/1275\/1113237\/pe1201001275.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/108\/6\/1275\/1113237\/pe1201001275.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:31:17Z","timestamp":1682746277000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/108\/6\/1275\/63619\/C-Reactive-Protein-in-Febrile-Children-1-to-36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12,1]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2001,12,1]]},"published-print":{"date-parts":[[2001,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.108.6.1275","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12,1]]}}}